NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 3 percent year over year uptick in its fiscal third quarter revenues driven primarily by the company's life science segment.

For the three months ended June 30, the Cincinnati-based life science and diagnostics firm logged revenues of $51.7 million compared to $50.1 million a year ago, falling short of analysts' consensus estimate of $52.1 million.